Eurosurveillance banner


Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring of 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Monthly Release  2002: Volume 7/ Issue 11 Article 2 Printer friendly version
Back to Table of Contents
en es fr
Previous Next

Eurosurveillance, Volume 7, Issue 11, 01 November 2002
Euroroundup
Development of a protocol to evaluate the quality of clinical influenza data collected by sentinel practitioners in Europe

Citation style for this article: Aguilera JF, Paget WJ, Van Der Velden J. Development of a protocol to evaluate the quality of clinical influenza data collected by sentinel practitioners in Europe. Euro Surveill. 2002;7(11):pii=374. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=374

JF Aguilera1, WJ Paget2, J van der Velden2

1 Respiratory Division, Public Health Laboratory Service Communicable Disease Surveillance Centre, London, United Kingdom
2 European Influenza Surveillance Scheme (EISS), Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands


EISS implemented an evaluation protocol to assess the quality of clinical data collected by sentinel networks for the surveillance of influenza. The protocol was applied in Belgium and in three regions in Spain where it resulted in recommendations to improve the national and regional surveillance networks.

Introduction

T he European Influenza Surveillance Scheme (EISS) aims to facilitate collaboration between European countries on influenza surveillance (see article p. 147-57). EISS has developed two protocols to evaluate the quality of clinical and virological data collected by surveillance networks based on sentinel practitionners (sp) reporting in Europe. The rationale for developing these protocols was to: a) move towards standardisation of data collection, b) improve the surveillance of influenza activity and data quality, c) facilitate the sharing of data at a European level, and d) encourage and facilitate access to new member states wanting to join the Scheme (1,2). This paper briefly describes the protocol to evaluate the quality of clinical data collected by SPs and the resulting experiences during the 2001–02 influenza season.

 

Methods

The EISS evaluation protocol is based on the Centers for Disease Control and Prevention (CDC Atlanta), and the World Health Organization (WHO) guidelines (2,3). We designed and pre-tested in the Netherlands and France two questionnaires to be administered: (a) face to face to the networks’ coordinators at regional and/or national level, and (b) either face to face or by telephone, depending on logistic constraints, to a representative sample of sentinel practitioners -in terms of either or both geographical location, and medical speciality (general practitioners/paediatricians).

The questionnaires addressed the following networks’ attributes, at the coordination and / or the sentinel practitioners’ levels:

• Sensitivity and specificity of the network, including information on the number of SPs and the use of : 1) a case definition for influenza and the adherence of SPs to it, 2) an epidemic threshold to estimate the magnitude of morbidity related to influenza, 3) incidence of ‘influenza-like illness’ (ILI) or ‘acute respiratory infection’ (ARI) as a numerator for measuring influenza activity, 4) a population-based or encounters-based denominator, 5) age groups for the classification of cases, and 6) criteria for collection of clinical specimens;

• Representativeness of sentinel practitioners to all national/regional practices, and of the population covered by sentinel practitioners to the general population;

• Timeliness for reporting weekly data, and ability to detect changes in trends in a timely way;

• Network output including reports, publications, communication, training to sentinel practitioners or staff, and activities leading to improved practice;

• Resources for the network.

We implemented the evaluation protocol during on site visits, at both coordination and sentinel practitioners levels, in the Belgian and three regional Spanish networks (Aragón, Castilla y León, and the Madrid Community). These networks were selected according to their EISS membership, the willingness of their coordinators to participate in the evaluation, logistic constraints, and because the EISS coordination centre wanted to evaluate a national network made up of regional networks (in Spain). The standardised evaluation protocol includes a report format to facilitate the formulation of conclusions and recommendations based on generally accepted surveillance practices, obtained from a literature review, WHO/CDC standards, current consensus reached within EISS, and surveillance practices in Europe (4).

Results

All networks fulfilled either international standards or EISS requirements in terms of : 1) simplicity and acceptability of influenza surveillance activities, 2) types of numerator (ILI in all networks as well as ARI in Belgium), age groups, denominators (population-based), case definitions and criteria for swabbing, 3) completeness of reports (over 95%), 4) use of epidemic thresholds (not used in Aragón), 5) laboratory support, 6) timeliness of reporting data and detecting trends, and 7) resources (see table).

Table. Preliminary results of the evaluation protocol

Caractéristiques /
Characteristics
Belgique /
Belgium
Espagne / Spain
   
Aragón
Castilla y León
Madrid

Evaluation sur site (jours)

On-site evaluation (days)

7

5

5

5

Population totale (million)*

Total population (million)*

10.1

1.2

2.5

5.4

Nombre de médecins sentinelles interviewés Number of sentinel practitioners interviewed

18 (35%)

10 (14%)

10 (29%)

9 (36%)

Nombre de médecins sentinelles et % de tous les médecins généralistes nationaux/régionaux /

Number of SPs and % of all national/regional GPs

51 (0.4%)

70 (7.0%)

35 (1.4%)

25 (3.4%)

Représentativité de la population couverte par le réseau

Representativeness of population covered by network

Géographique (province)
Geographical (province)

Age, facteurs socio-économiques Age, socio-economical factors

Age, urbain/rural/ facteurs socio-économiques Age, urban/rural, socio-economical factors

Age, sexe, urbain / rural

Age, sex, urban/rural

Pourcentage des médecins sentinelle interviewés utilisant la définition de cas standardisée du réseau

Percentage of interviewed SPs using the network standardised case definition

44%

30%

40%

11%

Nombre de prélèvements reçus par le laboratoire (saison 2001-2002)

Number of swabs received at the laboratory (2001-2002 season)

1 200

165

100

142

Délai moyen pour la déclaration des résultats des prélèvements aux médecins sentinelle (jours)

Average delay for reporting swab results to SPs (days)

2

11

18

21

*Estimée en janvier 2001 / Estimated in January 2001.
Le protocole d’évaluation a été mis en place par les réseaux de surveillance de la grippe en Belgique, et en Espagne (Castilla y León, Aragón et Madrid). Saison de la grippe 2001 – 2002 / The evaluation protocol was implemented in influenza surveillance networks in Belgium, and Spain (Castilla y León, Aragón and Madrid). Influenza season 2001–02.

Each network coordinator has received an evaluation report that is based on a standard format and includes a description of the network’s attributes, conclusions and recommendations. For all networks, the recommendations made to the coordinators included improving sentinel practitioners’ adherence to the national/regional case definitions and criteria for swabbing. Additionally, the following network-specific recommendations were made:

• In Belgium, to increase the number of sentinel practitioners, to improve their geographical representativeness, to organise regular meetings to discuss epidemiological and virological issues of the previous season, and to harmonise the methods used to establish the epidemic thresholds for ARI and ILI;

• In Spain, to increase the number of regional networks collecting and reporting clinical and virological data to the national level (currently eight out of 17 Spanish regions), and to improve the standardisation of methods used to establish epidemic thresholds in regional networks. At a regional level, to reduce the delay of reporting swab results to sentinel practitioners.

Conclusion

The EISS group has developed an evaluation protocol to assess the quality of clinical data collected by sentinel practitioners within EISS. This protocol allows an in-depth description of the surveillance network, and the sharing of national/regional experiences with other networks in Europe and elsewhere. It should facilitate the improvement and harmonisation of influenza surveillance activities in Europe, and be a valuable reference for new networks wanting to join EISS.

Acknowledgements

The Health and Consumer Protection Directorate-General of the European Commission funded this evaluation project. We would like to thank the following persons for testing and implementing the evaluation protocol:

Aad Bartelds (Netherlands Institute for Health Services Research, NIVEL, Utrecht): Anne Mosnier (France GROG, Paris); Fernande Yane and Frederic Pierquin (Institut Scientifique de Santé Publique, Brussels); Tomas Vega and Raul Ortiz de Lejarazu (Consejería de Sanidad y Bienestar Social y Centro de Gripe de Valladolid, Castilla y León); Maria Ordobas and Silvia Fernandes (Consejería de Sanidad, Comunidad de Madrid), Alberto Larrosa and Marta Fajó (Servicio Aragonés de Salud, Zaragoza); Manuel Omeñaca Teres (Laboratorio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza); Pilar Perez (Laboratorio de Referencia de Virología, Centro Nacional de Microbiología, Instituto Carlos III); Salvador de Mateo Ontañón (Servicio de Vigilancia Epidemiológica, Centro Nacional de Epidemiología, Madrid); and all sentinel practitioners who participated in the evaluation in Aragón, Belgium, Castilla y León, France, Madrid Community, and the Netherlands.

 

A copy of the evaluation protocol can be obtained by contacting Jean-Francois Aguilera (jaguilera@phls.org.uk). It will be posted on the EISS website (www.eiss.org) by the end of 2002.


References

1. WHO. Communicable Disease Surveillance and Response, Protocol for the evaluation of epidemiological surveillance systems. (http://www.who.int/emc-documents/surveillance/whoemcdis972c.html)

2. WHO. Department of Communicable Disease Surveillance and Response, Protocol for the assessment of national communicable disease surveillance and response systems; Guidelines for assessment teams. (http://www.who.int/emc-documents/surveillance/docs/whocdscsrisr20012.pdf)

3. CDC. Updated guidelines for evaluating surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep 2001; 50(RR13): 1-18. (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm)

4. Aguilera J-F, Paget WJ, Manuguerra J-C on behalf of EISS (European Influenza Surveillance Scheme) and EuroGROG. Survey of influenza surveillance systems in Europe. Report, December 2001.

 



Back to Table of Contents
en es fr
Previous Next

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved